|
⚲
|
| Keyboard |
| Perry Molinoff | |
|---|---|
| Firm | |
| Address | 17217 Waterview Parkway Suite 1202 Dallas, TX 75252 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Cersci Therapeutics Inc | 021-350547 | Director | 12.0 M of 12.0 M |
||
| Cynapsus Therapeutics Inc | 021-237893 | Director | 16.8 M of 16.8 M |
||
| Cynapsus Therapeutics Inc | 021-215923 | Director | 14.5 M of 42.9 M |
||
| Cynapsus Therapeutics Inc | 021-193597 | Director | of 2.4 M |
||
| Cynapsus Therapeutics Inc | 021-193385 | Director | 4.1 M of 13.0 M |
||
| Palatin Technologies Inc | 021-181225 | Director | 35.0 M of 35.0 M |
||
| Melior Pharmaceuticals I Inc | 021-166899 | Director | 0.4 M of 0.4 M |
||